Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.
about
Advances of Molecular Imaging in EpilepsyTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNSBlood-brain barrier active efflux transporters: ATP-binding cassette gene family.Drug resistance in brain diseases and the role of drug efflux transporters.Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy.Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in miceFunctional evidence of multidrug resistance transporters (MDR) in rodent olfactory epitheliumMultidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.ABC transporters, neural stem cells and neurogenesis--a different perspective.Drug transporters in the epileptic brain.ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's diseaseAlzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?Structure-activity relationship of cyanine tau aggregation inhibitors.P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.Intractable epilepsy and the P-glycoprotein hypothesis.Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain.Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine.Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables.Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
P2860
Q26750477-37FF4619-C319-406A-A341-CEE6A9ECB4D2Q27690256-994ED12F-C24E-40A9-AEB4-91C0225E166AQ33651875-53F02B80-6392-4CC0-B974-CF36A4A1471AQ33985133-FDBD1A00-346A-4076-AF71-C30F162F16E0Q33988704-76EDDF6C-7B58-4092-AC25-986C1FB9ACD7Q33995372-B4065D7F-30CE-4D87-A58F-13027D138D32Q34112939-A8B8BD6A-02FB-44AD-8BE8-62A0921E9197Q34212267-3235BE7D-E80C-4D14-8911-4BAAD79D17B9Q34260070-7DDF9A82-3932-45A2-8675-1F96BD152491Q35209207-D1FB8B4F-6DF6-4AD0-8EA4-BF2CAB9E5A01Q35708089-50FCB673-AB95-4A19-8735-AAB12057F420Q35814925-3F1C61B4-86AF-4268-8D2C-DDA31DC12EEBQ36023613-5F856AB1-D96F-49A8-AC6B-2DFC04B38ED9Q36157234-8246B363-600E-4AED-A449-C61435029FA4Q36341660-C47D31B6-DE57-4181-A2B2-0A515ACF912DQ36646747-88AE0BA2-2474-4D6F-8614-04297AD9B315Q36742736-A9E75DD4-0987-469B-AA07-C62117D69429Q36957955-B5CBFDCC-B2C3-45A2-9B13-CA87E324886DQ37091141-FEF6F2EC-F128-439D-A6E0-CC5B3474CDB9Q37239081-F79FC320-D52E-49DC-A363-F0EF318CF74CQ37253310-F5403088-0727-48C5-9048-5902BD74A880Q37349368-1D48B256-53F0-41CD-A679-8C4A5A03BED1Q38259301-F9B6E6CF-84B8-4D2E-8DFE-A4462D8E7C90Q38497941-67F8DAAE-2381-470F-837D-ADBB7A950F90Q42091226-E4A59BA6-255E-4D7B-B5B8-D103AD2CFD91Q44998746-A9E08BA9-C952-47F8-AAF8-B5056A889F43Q46417699-5608DE69-D46E-405F-AB64-1961E274B58BQ46725859-C95DA932-34FF-4C21-84E2-BF97D4EECA07Q48116760-82BDF17C-21A0-448A-BDFA-671256A92051Q48201303-321622F6-008C-459D-A28E-C64382D009EEQ48510594-C93DC03B-2C0A-4692-BCBA-161ED903C726Q48560275-C7D1A2BC-D82D-441D-BDD5-31CA2B884F6C
P2860
Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Neuronal expression of the dru ...... ocampus after limbic seizures.
@en
Neuronal expression of the dru ...... ocampus after limbic seizures.
@nl
type
label
Neuronal expression of the dru ...... ocampus after limbic seizures.
@en
Neuronal expression of the dru ...... ocampus after limbic seizures.
@nl
prefLabel
Neuronal expression of the dru ...... ocampus after limbic seizures.
@en
Neuronal expression of the dru ...... ocampus after limbic seizures.
@nl
P2093
P1433
P1476
Neuronal expression of the dru ...... pocampus after limbic seizures
@en
P2093
P304
P356
10.1016/J.NEUROSCIENCE.2003.10.012
P407
P577
2004-01-01T00:00:00Z